Biden is most likely to choose NCI's Bertagnolli to lead NIH.

Published Date: 22 Apr 2023

The National Cancer Plan was created by Dr. Monica Bertagnolli at the National Cancer Institute to assist President Joe Biden's Cancer Moonshot initiative.

Read Full News

Latest News

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Health Data Platform Connects Hospitals Across Provinces

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

News All Time

Freezing of Gait in Parkinson’s: What’s Beyond Medication?

A conference review highlights how combining cognitive, motor, and sensory training with cueing strategies may improve freezing of gait in Parkinson’s disease.

What Doctors Should Know About Autism ‘Unmasking’ in Girls

More teen girls and young women are self-identifying as autistic, giving clinicians a unique opportunity to help patients that goes beyond confirming or ruling out a diagnosis.

What the Fourth Year of Med School Is Really Like

Fourth-year med students are in for a lot of stress, anxiety, and expense, just not from studying.

Home Eye Scans Best Suited for High-Cost Retina Meds

Home-based optical tomography may only be cost-effective for patients on more expensive treatments.

Low-FODMAP Diet May Ease Symptoms of Postprandial Dyspepsia

A diet low in fermentable carbohydrates offers better symptom relief and quality of life than traditional dietary advice in adults with postprandial distress syndrome.

Why Paris Faces Europe’s Highest Heat Death Risk

New research suggests extreme heat can worsen neurologic disease, pregnancy outcomes, and mortality, with risk driven as much by poverty and housing as by temperature.

Why France Is Leading on Tick-Borne Diseases

France has built a national tick-borne disease network, expanded PTLDS guidance, and launched new cohorts to track Lyme disease from bite to long-term outcomes.

Hepatitis B Vaccination Crucial for Guinea-Bissau: Ethicist

Ethicist Art Caplan discusses hepatitis B vaccination and ethical considerations for a suspended clinical trial in Guinea-Bissau.

Population-Wide CRC Screening May Cut Health Inequities

After launching an organized CRC screening program in Hong Kong, socioeconomic disparities have narrowed but persist among certain groups.

Medical Cannabis: What to Tell Your Patients

Evidence supports cannabis-based therapies for a limited number of conditions. Here’'s what clinicians should know — and tell patients — about the potential benefits, risks, and remaining uncertainties.

Poor Access to MASLD Care for Most US Patients

Most US counties lack access to elastography imaging, gastroenterologists, or both, creating major geographic gaps in care for MASLD.

Tavapadon Improves Early PD Symptoms: Full Phase 3 Results

The selective D1/D5 agonist significantly improved Parkinson’s disease motor symptoms, with low rates of somnolence and impulse control disorders, full results of the phase 3 TEMPO-2 study show.

Work Stress Predicts Depression Among Ambulance Staff

An explanatory study identifies organisational stressors, a lack of mental rest, and stress appraisals as vital predictors of depression among ambulance staff.

TIPS in Liver Failure With Fluid Overload Reduces Death Risk

Transjugular intrahepatic portosystemic shunt insertion is associated with a lower risk for short-term mortality in patients with acute-on-chronic liver failure with fluid overload.

England to Screen Newborns for Spinal Muscular Atrophy

The rollout follows Scotland’s lead and was fast-tracked after a parliamentary debate and a 150,000-signature petition.

The Alarming Rise of Early-Onset Lung and GI Cancers

At ASCO 2026, Drs Olazagasti and Bernabe discuss the rise of early-onset cancers and how to close critical screening gaps.

Recommended News For You

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

What is Mohs micrographic surgery? 8 FAQs about Mohs

Sports for girls are frequently abandoned due to uniform issues.

Study finds 81% of cancer cures touted by TikTok videos are fake

Breast Cancer Incidence Rises in Asian American Women

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

Distribution of fat could influence cancer risk, study suggests

Recommended Articles For You

Strategic Solutions in Oncology for Modern Medicine 

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

2.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

5.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

1.

A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era

2.

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions

3.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

4.

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances

5.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VIII

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot